Chimeric Virus-like Particles of Bacteriophage Beihai32, Displaying the M2e Peptide and Conserved Antigens from the Hemagglutinin and Neuraminidase of the Influenza A Virus as a Platform for Recombinant Vaccine Development

Despite the widespread use of seasonal influenza vaccines, the high antigenic variability of influenza A viruses necessitates the development of recombinant vaccines capable of eliciting broadly cross-protective immune responses. Conserved peptide antigens of the influenza A virus represent promising targets for the development of such vaccines. However, these antigens are poorly immunogenic and therefore require efficient presentation platforms to enhance their immunogenicity. Virus-like particles (VLPs) assembled from bacteriophage capsid proteins (CPs) constitute a promising platform due to their ability to display antigens at high density. In this study, chimeric VLPs were constructed using the Beihai32 bacteriophage capsid protein as a scaffold. Three conserved neuraminidase epitopes, two copies of the conserved hemagglutinin stalk fragment (HA2), and four copies of the M2e peptide (232 a.a. in total) were fused to the C-terminus of the CP. The recombinant protein was expressed in E. coli and self-assembled into spherical VLPs approximately 30 nm in size. ELISAs revealed that the M2e and HA2 peptides in the chimeric VLPs were accessible to specific antibodies, suggesting their surface exposure. Chimeric VLPs were recognized by anti-CP antibodies with less efficiency than VLPs formed by empty CP, indicating shielding of the CP core. Subcutaneous immunization of mice with the chimeric VLPs induced high titers of M2e- and HA2-specific IgG antibodies, as well as antibodies to neuraminidase epitopes. Thus, fusion of multiple influenza A virus antigens with the Beihai32 capsid protein enables the assembly of immunogenic VLPs, highlighting their potential as a platform for the development of recombinant influenza vaccines.

Authors

Institutions

Publication Details

Journal
Biomolecules
Published
2026-11-18
DOI
https://doi.org/10.3390/biom16111680
Primary Topic
Influenza Virus Research Studies
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Chimeric Virus-like Particles of Bacteriophage Beihai32, Displaying the M2e Peptide and Conserved Antigens from the Hemagglutinin and Neuraminidase of the Influenza A Virus as a Platform for Recombinant Vaccine Development

Eugenia S. Mardanova, Nikolai V. Ravin, Anna A. Zykova, Marina A. Shuklina et al.
6 links
Biomolecules
Influenza Virus Research Studies
article

Chimeric Virus-like Particles of Bacteriophage Beihai32, Displaying the M2e Peptide and Conserved Antigens from the Hemagglutinin and Neuraminidase of the Influenza A Virus as a Platform for Recombinant Vaccine Development

Eugenia S. Mardanova, Nikolai V. Ravin, Anna A. Zykova, Marina A. Shuklina, Sergey A. Klotchenko, Olga O. Ozhereleva, Elena A. Blokhina
article en

Abstract

Despite the widespread use of seasonal influenza vaccines, the high antigenic variability of influenza A viruses necessitates the development of recombinant vaccines capable of eliciting broadly cross-protective immune responses. Conserved peptide antigens of the influenza A virus represent promising targets for the development of such vaccines. However, these antigens are poorly immunogenic and therefore require efficient presentation platforms to enhance their immunogenicity. Virus-like particles (VLPs) assembled from bacteriophage capsid proteins (CPs) constitute a promising platform due to their ability to display antigens at high density. In this study, chimeric VLPs were constructed using the Beihai32 bacteriophage capsid protein as a scaffold. Three conserved neuraminidase epitopes, two copies of the conserved hemagglutinin stalk fragment (HA2), and four copies of the M2e peptide (232 a.a. in total) were fused to the C-terminus of the CP. The recombinant protein was expressed in E. coli and self-assembled into spherical VLPs approximately 30 nm in size. ELISAs revealed that the M2e and HA2 peptides in the chimeric VLPs were accessible to specific antibodies, suggesting their surface exposure. Chimeric VLPs were recognized by anti-CP antibodies with less efficiency than VLPs formed by empty CP, indicating shielding of the CP core. Subcutaneous immunization of mice with the chimeric VLPs induced high titers of M2e- and HA2-specific IgG antibodies, as well as antibodies to neuraminidase epitopes. Thus, fusion of multiple influenza A virus antigens with the Beihai32 capsid protein enables the assembly of immunogenic VLPs, highlighting their potential as a platform for the development of recombinant influenza vaccines.

BiomoleculesVol. 16(11)
Russian Academy of Sciences (RU), Ministry of Health of the Russian Federation (RU), Research Institute of Influenza (RU)
Ministry of Science and Higher Education of the Russian Federation
Good health and well-being
Influenza Virus Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon